Radiotherapy News and Research

RSS

Radiation therapy (in North America), or radiotherapy (in the UK and Australia) also called radiation oncology, and sometimes abbreviated to XRT, is the medical use of ionizing radiation as part of cancer treatment to control malignant cells (not to be confused with radiology, the use of radiation in medical imaging and diagnosis).

ASTRO's new guideline provides recommendations for radiation therapy to treat cervical cancer

A new clinical guideline from the American Society for Radiation Oncology provides recommendations for radiation therapy to treat patients with nonmetastatic cervical cancer.

10 Jun 2020

Better testing could lead to improved treatments for a specific type of ovarian cancer

Scientists have found that a specific type of ovarian cancer could possibly benefit from existing platinum-based chemotherapy and new DNA repairing treatments, following better testing.

8 Jun 2020

Study investigates combined effects of cancer therapy and inherited genetics

Scientists at St. Jude Children's Research Hospital are studying the combined effect of cancer treatments and inherited mutations in DNA-repair genes.

5 Jun 2020

Oral antidiabetics improve outcomes in diabetics with colorectal cancer

Bottom Line: Among patients with both colorectal cancer and diabetes in Korea, those who had a high adherence to their oral diabetes medication had a significantly reduced risk of overall mortality compared with those with lower adherence.

1 Jun 2020

Genetic screening could be effective at detecting undiagnosed cases of prostate cancer

Genetic screening for prostate cancer in GP surgeries could be effective at picking up otherwise undiagnosed cases of the disease, a new pilot study shows.

31 May 2020

Monoclonal antibody therapy achieves modest reduction in recurrence for patients with HER2-positive DCIS

The addition of the monoclonal antibody therapy Trastuzumab to radiotherapy did not reach the protocol objective of a 36% reduction in the ipsilateral breast tumor recurrence rate for women with HER2-positive ductal carcinoma in situ (DCIS) on the NRG Oncology clinical trial NSABP B-43.

29 May 2020

Addition of monoclonal antibody to trimodality therapy offers no benefit in HER2 over expressing esophageal cancer

Results of the NRG Oncology clinical trial RTOG 1010 indicated that the addition of the monoclonal antibody trastuzumab to neoadjuvant trimodality treatment did not improve disease-free survival outcomes for patient with HER2 overexpressing local and locally advanced esophageal adenocarcinoma.

29 May 2020

Characterizing immune cells in malignant brain tumors

It is not always possible to completely remove malignant brain tumors by surgery so that further treatment is necessary.

28 May 2020

A promising method for treating triple-negative breast cancer

Researchers at the University of Queensland may have found a way to improve treatment of triple-negative breast cancer.

27 May 2020

Researchers identify genetic mechanisms that produce radioresistance in cancer cells

Cancer stem cells are a cell type that was previously little known. They are resistant to irradiation and prevent the effective treatment of many types of cancer. A research group from Innsbruck has now identified two genetic mechanisms that produce this radioresistance.

26 May 2020

Radiation oncology clinics report fewer patients despite improved safety measures

Despite facing challenges such as limited access to personal protective equipment (PPE) following the COVID-19 outbreak, radiation oncology clinics quickly implemented safety and process enhancements that allowed them to continue caring for cancer patients, according to a new national survey from the American Society for Radiation Oncology (ASTRO).

20 May 2020

Study examines 5-aminolevulinic acid induced fluorescence in surgery of brain metastases

Two-thirds of brain metastases give off fluorescence following administration of 5-aminolevulinic acid, which could potentially assist surgeons in identifying such tumors.

20 May 2020

Nomograms can predict the risk of treatment delays for head and neck cancer patients

More than 65,000 Americans are diagnosed annually with head and neck cancer, which most often occurs inside the mouth and throat. For patients who undergo surgery to treat this cancer, guidelines recommend that prompt initiation of radiotherapy -- within six weeks -- is critical for best outcomes.

13 May 2020

More selective elimination of leukemic and hematopoietic stem cells

Acute myeloid leukemia is an aggressive cancer of the blood-forming system. It affects the hematopoietic stem cells, or blood stem cells, of various white blood cells and of the red blood cells and platelets.

8 May 2020

Combination of schizophrenia drug and radiation shows promise in treating glioblastoma

Researchers at the UCLA Jonsson Comprehensive Cancer Center and colleagues have found that adding a drug once commonly used to treat schizophrenia to traditional radiation therapy helped improve overall survival in mice with glioblastoma, one of the deadliest and most difficult-to-treat brain tumors.

2 May 2020

Prostate cancer mortality rates predicted to fall in the EU but rise in Poland

Death rates from prostate cancer are predicted to fall in 2020 in the EU, largely due to better diagnosis and treatment, according to new research published in the leading cancer journal Annals of Oncology today (Monday).

20 Apr 2020

Oncological care in the COVID-19 era

In Nature Medicine, the seven comprehensive cancer centres of Cancer Core Europe, including the Netherlands Cancer Institute and Cancer Research UK Cambridge Centre, have shared how they rapidly reorganized their oncological healthcare systems during the COVID-19 pandemic.

18 Apr 2020

Radiotherapy News and Research

Further Reading

ASTRO's new guideline provides recommendations for radiation therapy to treat cervical cancer

Better testing could lead to improved treatments for a specific type of ovarian cancer

Study investigates combined effects of cancer therapy and inherited genetics

Oral antidiabetics improve outcomes in diabetics with colorectal cancer

Genetic screening could be effective at detecting undiagnosed cases of prostate cancer

Monoclonal antibody therapy achieves modest reduction in recurrence for patients with HER2-positive DCIS

Addition of monoclonal antibody to trimodality therapy offers no benefit in HER2 over expressing esophageal cancer

Characterizing immune cells in malignant brain tumors

A promising method for treating triple-negative breast cancer

Researchers identify genetic mechanisms that produce radioresistance in cancer cells

Radiation oncology clinics report fewer patients despite improved safety measures

Study examines 5-aminolevulinic acid induced fluorescence in surgery of brain metastases

Nomograms can predict the risk of treatment delays for head and neck cancer patients

More selective elimination of leukemic and hematopoietic stem cells

Combination of schizophrenia drug and radiation shows promise in treating glioblastoma

Prostate cancer mortality rates predicted to fall in the EU but rise in Poland

Oncological care in the COVID-19 era

Death rates from prostate cancer predicted to decline overall in EU

China with the world: COVID-19 experts dialogues - the 4th talk transcript

Shorter-course radiotherapy will benefit bowel cancer patients during COVID-19

Cancer Research eBook

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News